REG - Kibo Energy PLC - Kibo Subsidiary Announces AGM Results

Kibo EnergyAnnouncement

30/05/2024 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240530:nRSd5071Qa&default-theme=true

RNS Number : 5071Q  Kibo Energy PLC  30 May 2024

Kibo Energy PLC (Incorporated in Ireland)

(Registration Number: 451931)

(External registration number: 2011/007371/10)

LEI Code: 635400WTCRIZB6TVGZ23

Share code on the JSE Limited: KBO

Share code on the AIM: KIBO

ISIN: IE00B97C0C31

('Kibo' or 'the Company')

 

Dated: 30 May 2024

 

Kibo Energy PLC ('Kibo' or the 'Company')

 

Kibo Subsidiary Announces AGM Results

 

Kibo Energy PLC (AIM: KIBO; AltX: KBO), the renewable energy-focused
development company, announces the results of the AGM held today of its
subsidiary Mast Energy Developments PLC ('MED'), a UK-based multi-asset owner,
developer and operator in the rapidly growing flexible power market.

 

Further details can be found in the full MED RNS Announcement, which is
available below and at med.energy (https://med.energy/?page_id=3140) .

 

-------------------------

30 May 2024

 

Mast Energy Developments PLC

 

Results of Annual General Meeting

 

Mast Energy Developments PLC ("MED" or "the Company") the UK-based multi-asset
operator in the rapidly growing Reserve Power market, announces the results of
voting at its Annual General Meeting ("AGM") held today.

 

Proxies were received by shareholders holding 61.45% of the shares in MED
(426,354,067 shares issued and outstanding). All Resolutions were carried.

 

The proxy voting details at the AGM are shown on the table below:

 Resolution #  *Summary Resolution                                                             Votes cast For &           Votes cast          Votes Withheld

                                                                                               With Discretion            Against
                                                                                               Number        %            Number      %       Number
 1.            To receive and adopt the accounts and reports for the financial year ended 31
               December 2023.

                                                                                               261,871,936   99.96        113,885     0.04    0
 2.            To appoint Crowe UK LLP as auditors of the Company and to authorise the                                                        0
               directors to determine their remuneration

                                                                                               261,871,936   99.96        113,885     0.04
 3.            To re-elect Mr Dominic Traynor as a Director of the Company                                   97.06        7,713,885   2.94    10,000

                                                                                               254,261,936

 4.            THAT the Directors be, and they are hereby generally and unconditionally        260,210,634   99.32        1,775,187   0.68    0
               authorised to exercise all powers of the Company to allot relevant securities

 5.            THAT the Directors be, and they are hereby empowered pursuant to Section 570
               of the Act to allot equity securities

                                                                                               260,200,634   99.32        1,785,187   0.68    0
 * The full text of the Resolutions  can be found on the Notice of AGM on the
 MED website at:
 https://med.energy/wp-content/uploads/2022/04/MED-2024-Notice-of-AGM-Final.pdf
 (https://med.energy/wp-content/uploads/2022/04/MED-2024-Notice-of-AGM-Final.pdf)

 

ENDS

 

This announcement contains inside information for the purposes of the UK
version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of
United Kingdom domestic law by virtue of the European Union (Withdrawal) Act
2018 ('UK MAR'). Upon the publication of this announcement, this inside
information is now considered to be in the public domain.

 

For further information please visit www.med.energy (http://www.med.energy/)
or contact:

 Pieter Krügel   info@med.energy (mailto:info@med.energy)  Mast Energy Developments PLC  CEO
 Jon Belliss     +44 (0)20 7399 9425                       Novum Securities              Corporate Broker

_______________________

 

**ENDS**

 

For further information please visit www.kibo.energy (http://www.kibo.energy/)
or contact:

 

 Louis Coetzee                info@kibo.energy (mailto:info@kibo.energy)  Kibo Energy PLC             Chief Executive Officer
 James Biddle Roland Cornish  +44 207 628 3396                            Beaumont Cornish Limited    Nominated Adviser
 Claire Noyce                 +44 20 3764 2341                            Hybridan LLP                Joint Broker
 Damon Heath                  +44 207 186 9952                            Shard Capital Partners LLP  Joint Broker

 

Beaumont Cornish Limited ('Beaumont Cornish') is the Company's Nominated
Adviser and is authorised and regulated by the FCA. Beaumont Cornish's
responsibilities as the Company's Nominated Adviser, including a
responsibility to advise and guide the Company on its responsibilities under
the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed
solely to the London Stock Exchange. Beaumont Cornish is not acting for and
will not be responsible to any other persons for providing protections
afforded to customers of Beaumont Cornish nor for advising them in relation to
the proposed arrangements described in this announcement or any matter
referred to in it.

 

Johannesburg

30 May 2024

Corporate and Designated Adviser

River Group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCQKKBPBBKDKPN